Brian Higgins

Official portrait, 2005 Brian Michael Higgins (born October 6, 1959) is an American former politician who was the U.S. representative for , from 2005 until 2024. The district, numbered as the 27th district from 2005 to 2013 and as the 26th from 2013 to 2024, included Buffalo and Niagara Falls, along with some surrounding urban and suburban areas. Higgins is a member of the Democratic Party, and of several congressional committees and caucuses. He was born and raised Buffalo, New York, before obtaining a bachelor's and master's from Buffalo State College and an MPA from Harvard University. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Brian Higgins', query time: 0.04s Refine Results
  1. 1
    Supporting Early and Ongoing University Student Experiences Through ‘Academic Skills Adviser’ Services

    Supporting Early and Ongoing University Student Experiences Through ‘Academic Skills Adviser’ Services by Brian Higgins, Margot Reeh, Peter Cahill, David Duncan

    Published 2015-10-01
    Get full text
    Article
  2. 2
    Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa

    Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentra... by Hosuk Ryou, Korsuk Sirinukunwattana, Ruby Wood, Alan Aberdeen, Jens Rittscher, Olga K. Weinberg, Robert Hasserjian, Olga Pozdnyakova, Frank Peale, Brian Higgins, Pontus Lundberg, Kerstin Trunzer, Claire N. Harrison, Daniel Royston

    Published 2024-06-01
    Get full text
    Article
  3. 3
    Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease

    Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease by Mary T. Scott, Wei Liu, Rebecca Mitchell, Cassie J. Clarke, Ross Kinstrie, Felix Warren, Hassan Almasoudi, Thomas Stevens, Karen Dunn, John Pritchard, Mark E. Drotar, Alison M. Michie, Heather G. Jørgensen, Brian Higgins, Mhairi Copland, David Vetrie

    Published 2024-01-01
    Get full text
    Article
  4. 4
    A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial

    A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial by Srdan Verstovsek, Moshe Talpaz, Martha Wadleigh, Alessandro Isidori, Peter te Boekhorst, Michael R. Savona, Prithviraj Bose, Olga Pozdnyakova, Ruben Mesa, Tarec C. El-Galaly, Jennifer O’Sullivan, Katia Gamel, Brian Higgins, Sudhakar Katakam, Boyan Todorov, Kerstin Trunzer, Claire N. Harrison

    Published 2024-01-01
    Get full text
    Article
  5. 5
    Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

    Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial by Srdan Verstovsek, Lynda Foltz, Vikas Gupta, Robert Hasserjian, Taghi Manshouri, John Mascarenhas, Ruben Mesa, Olga Pozdnyakova, Ellen Ritchie, Ivo Veletic, Katia Gamel, Habib Hamidi, Lyrialle Han, Brian Higgins, Kerstin Trunzer, Marianne Uguen, Dao Wang, Tarec Christoffer El-Galaly, Boyan Todorov, Jason Gotlib

    Published 2023-05-01
    Get full text
    Article

Search Tools: